CohBar Appoints Joanne Yun, Ph.D. to Its Board of Directors

    NEXT STORY
    AXIM® Biotech Appoints Ophthalmic Industry Veteran Jeff Busby as Senior VP Business Development
    PREV STORY
    Junshi Biosciences and Coherus Announce Results from Phase 3 Study of Toripalimab Published in September Issue of Nature Medicine
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Avadel Presents New Clinical Data from Pivotal Phase 3 REST-ON Trial Supporting Clinical Benefit of FT218 in Patients with Narcolepsy at SLEEP 2021

    author_avatar
    NASDAQ Market News

    Cue Biopharma to Host Investor Business Update Call and Webcast

    Update on progress of selective immune modulation platformCAMBRIDGE, Mass., Aug. 14, 2018 (GLOBE NEWSWIRE) ...

    author_avatar
    NASDAQ Market News

    UPDATE — OpGen to Present Antibiotic Resistance Prediction Data at 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

    GAITHERSBURG, Md., April 13, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that ...

    author_avatar
    NASDAQ Market News